When Wall Street's most powerful bank pays over $2 billion for a small ETF shop, it's a clear signal about where the industry thinks money is heading — away from old mutual funds and into ETFs. Goldman is effectively buying growth in the fastest-growing c

Verdict: wait for the cross — the thesis is real, the evidence is one trade

The ETF-consolidation thesis behind Goldman's reported $2.3 billion Neos deal (per the Bloomberg piece from August 24) is real and well-funded: Goldman earned a 13.7% return on equity in FY2025 — roughly the 81st percentile of Financials peers — with diluted EPS up 154% year over year and $164B of cash against the purchase price. But the entire backtest rests on a single Goldman trade (27.8% over 60 months, 7.8% max drawdown), the 24-month window produced zero triggers, and exits were filled on daily bars, so the reported win rate is coarse. The tight 2.3% stop against a stock with 34.8% annualized volatility makes a whipsaw exit quite plausible, and the deal itself is still only being 'discussed,' nothing signed. With Goldman's 20-day average about $4.07 away from confirming the cross and MACD still below its signal line, the correct posture is to wait for the trigger, not to pre-position. **Conviction breakdown:** Thesis support 68 — the deal logic and peer earnings (BlackRock revenue up 18.7%, Morgan Stanley ROE 15.1%) genuinely support the ETF-boom story. Trade readiness 55 — the setup is one condition from arming but no cross has printed. Risk quality 45 — a 2.3% hard stop and a 41.5% expected portfolio drawdown profile are unforgiving. Backtest evidence 35 — one trade is one data point, however good. Fundamentals trend 65 — profitability is top-quartile, though negative free cash flow and rising MS leverage temper it.

Trade now

**The GS leg of this idea is one condition away from arming.** Goldman closed at $1,058.88, and the entry needs four things to line up on the daily chart: the 20-day average (now $1,040.22) crossing above the 50-day average ($1,036.15), RSI (14) above 50 but below 70, and a MACD bullish crossover. RSI at 59.3 clears both bands with room to spare, and the 20-day sits about $4.07 above the 50-day — close, but a *cross* event hasn't fired; the averages have to actually swap on a closing basis. So today's action is simple: **wait**. That means no shares until the EMA crossover and the MACD line crossing above its signal line both print on a completed daily bar, ideally the same bar as the RSI band holding. **If the trigger fires, the risk geometry is defined.** The strategy's percentage-based exits do the work here: a hard stop at 2.3% below entry (roughly $1,034 on today's price) and a take-profit at 4.6% above (roughly $1,108), for an effective reward-to-risk of about 2-to-1 before the Fibonacci-extension target at 127.2% or the deeper structural levels come into play. A close back below the 20/50-day averages or a daily close under the second support shelf near $1,001 would also signal the setup is failing. Sizing is capped at 25% of the book per position, so "wait" doesn't mean small — it means don't pre-position before the cross confirms. **The evidence base is one good trade, so treat the 100% win rate with respect, not awe.** Over the 60-month backtest the GS leg produced a single trade returning 27.8% with a 7.8% peak-to-trough drawdown, and the more recent 24-month window produced no entries at all — the crossover simply didn't set up. That's consistent with a patient, low-frequency system, not a broken one; exits were also filled on daily bars rather than intraday, so drawdown and win-rate figures are coarse. Note as well that no robust nearby-parameter setup was established, so this is the thesis-defined trigger, not an optimized one. The peer signals (BlackRock RSI 64.1, Morgan Stanley RSI 47.6) suggest the ETF-complex rally thesis has breadth — Goldman is the one waiting for its technical green light.

Buying growth instead of building it

The core of the idea is that Goldman's reported $2.3 billion Neos acquisition (per the Bloomberg video from August 24, 2026) is a strategic purchase of growth in the fastest-growing corner of asset management. That reading is supported by Goldman's own results: FY2025 diluted EPS of $51.32, up a striking 154% year over year, with net income of $17.2B on $125B of equity — a return on equity of 13.7%, which sits in roughly the 81st percentile of Financials peers.…

Scores

• Conviction score breakdown: 54
• Thesis support: 68
• Trade readiness: 55
• Risk quality: 45
• Backtest evidence: 35
• Fundamentals trend: 65

Watch items

• GS — 20-day vs 50-day EMA (daily close)
• GS — RSI (14)
• GS — MACD (12,26,9) line vs signal
• MS — RSI (14)
• BLK — RSI (14)
• GS — Daily close (percentage stop)
• GS — RSI (14)
• BLK — EMA (20) crossed above EMA (50)
• BLK — RSI (14) above 50
• BLK — RSI (14) below 70
• BLK — MACD (12,26,9) crossed above MACD (12,26,9)